Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1988 1
1990 3
1992 1
1994 1
1996 3
1997 1
1998 3
1999 3
2000 10
2001 4
2002 10
2003 2
2004 4
2006 1
2007 4
2008 3
2009 2
2010 3
2012 1
2013 1
2014 1
2015 1
2016 1
2017 1
2018 1
2019 1
2020 1
2021 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial.
van der Heijde D, Cheng-Chung Wei J, Dougados M, Mease P, Deodhar A, Maksymowych WP, Van den Bosch F, Sieper J, Tomita T, Landewé R, Zhao F, Krishnan E, Adams DH, Pangallo B, Carlier H; COAST-V study group. van der Heijde D, et al. Lancet. 2018 Dec 8;392(10163):2441-2451. doi: 10.1016/S0140-6736(18)31946-9. Epub 2018 Oct 22. Lancet. 2018. PMID: 30360964 Clinical Trial.
Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial.
Deodhar A, van der Heijde D, Gensler LS, Kim TH, Maksymowych WP, Østergaard M, Poddubnyy D, Marzo-Ortega H, Bessette L, Tomita T, Leung A, Hojnik M, Gallo G, Li X, Adams D, Carlier H, Sieper J; COAST-X Study Group. Deodhar A, et al. Lancet. 2020 Jan 4;395(10217):53-64. doi: 10.1016/S0140-6736(19)32971-X. Epub 2019 Dec 5. Lancet. 2020. PMID: 31813637 Clinical Trial.
Autoantibodies in autoimmune diseases.
Eggert M, Zettl UK, Neeck G. Eggert M, et al. Among authors: neeck g. Curr Pharm Des. 2010 May;16(14):1634-43. doi: 10.2174/138161210791164144. Curr Pharm Des. 2010. PMID: 20196735 Review.
Pathogenic mechanisms of fibromyalgia.
Neeck G. Neeck G. Ageing Res Rev. 2002 Apr;1(2):243-55. doi: 10.1016/s1568-1637(01)00004-6. Ageing Res Rev. 2002. PMID: 12039441 Review.
Hormonal pertubations in fibromyalgia syndrome.
Neeck G, Riedel W. Neeck G, et al. Ann N Y Acad Sci. 1999 Jun 22;876:325-38; discussion 339. doi: 10.1111/j.1749-6632.1999.tb07657.x. Ann N Y Acad Sci. 1999. PMID: 10415628 Review.
Transcription factors in autoimmune diseases.
Eggert M, Klüter A, Zettl UK, Neeck G. Eggert M, et al. Among authors: neeck g. Curr Pharm Des. 2004;10(23):2787-96. doi: 10.2174/1381612043383593. Curr Pharm Des. 2004. PMID: 15379667 Review.
67 results